Ian J. Neeland, MD
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Ian J. Neeland, MD sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Ian J. Neeland, MD: 4 sponsored US clinical trials, 3 recruiting.
Ian J. Neeland, MD sponsors 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Food Acceptance, with 1 trials.
Upper-quartile sponsor footprint
Ian J. Neeland, MD sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Dietary Peanuts and Nutrition-Related Outcomes
NCT07244458
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
NCT07244445
Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes
NCT05933174
Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes
NCT05523362
Therapeutic Areas
What is open in the Ian J. Neeland, MD pipeline
3 recruiting of 4 indexed (75% open); 1 completed (25%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Food Acceptance (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Ian J. Neeland, MD: open-pipeline peers nationwide
Peers matched on 4 registered trials and 75% open enrollment, not the therapeutic-area sidebar.
Ian J. Neeland, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 75% open enrollment (± trial volume)
- Acepodia Biotech · 75% recruiting · 4 trials
- American Laboratory Products Company · 75% recruiting · 4 trials
- Amryt Pharma · 75% recruiting · 4 trials
- Amydis · 75% recruiting · 4 trials
Related
What to do with this Ian J. Neeland, MD page
4 registered trials is a research-attention snapshot, not an endorsement of Ian J. Neeland, MD or any single study.
- 3 of Ian J. Neeland, MD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Food Acceptance is the condition Ian J. Neeland, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Food Acceptance trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Ian J. Neeland, MD pipeline card: 4 registered trials from official public datasets.Report a data error.